EUVIMEDEUVIMED entdecken
Crossref

Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-β Plaque Burden

Takaya Suganuma, Sena Hatori, Chung-Kuan Chen, Satoshi Hori, Mika Kanuka, Chih-Yao Liu, Chika Tatsuzawa, Masashi Yanagisawa, Yu Hayashi

Journal of Alzheimer’s Disease · 2024

DOI: 10.3233/jad-240033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Takaya Suganuma und 8 weiteren Autor:innen. Beteiligte Einrichtung: International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Japan. Hauptthemen laut MEDLINE: Quinic Acid, Plaque, Amyloid, Mice, Transgenic, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Caffeoylquinic acid (CQA), which is abundant in coffee beans and Centella asiatica, reportedly improves cognitive function in Alzheimer’s disease (AD) model mice, but its effects on neuroinflammation, neuronal loss, and the amyloid-β (Aβ) plaque burden have remained unclear.

Objective

To assess the effects of a 16-week treatment with CQA on recognition memory, working memory, Aβ levels, neuronal loss, neuroinflammation, and gene expression in the brains of 5XFAD mice, a commonly used mouse model of familial AD.

Methods

5XFAD mice at 7 weeks of age were fed a 0.8% CQA-containing diet for 4 months and then underwent novel object recognition (NOR) and Y-maze tests. The Aβ levels and plaque burden were analyzed by enzyme-linked immunosorbent assay and immunofluorescent staining, respectively. Immunostaining of markers of mature neurons, synapses, and glial cells was analyzed. AmpliSeq transcriptome analysis and quantitative reverse-transcription-polymerase chain reaction were performed to assess the effect of CQA on gene expression levels in the cerebral cortex of the 5XFAD mice.

Results

CQA treatment for 4 months improved recognition memory and ameliorated the reduction of mature neurons and synaptic function-related gene mRNAs. The Aβ levels, plaque burden, and glial markers of neuroinflammation seemed unaffected.

Conclusions

These findings suggest that CQA treatment mitigates neuronal loss and improves cognitive function without reducing Aβ levels or neuroinflammation. Thus, CQA is a potential therapeutic compound for AD, improving cognitive function via as-yet unknown mechanisms independent of reductions in Aβ or neuroinflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quinic AcidPlaque, AmyloidMice, TransgenicNeuronsCognitive DysfunctionDisease Models, AnimalAnimalsMiceAmyloid beta-PeptidesAlzheimer DiseaseMaleMaze Learning

Stichwörter der Autor:innen

Alzheimer’s diseaseDeepLabCutamyloid-βcaffeoylquinic acidchlorogenic acidcoffeecognition

Substanzen

Quinic Acidcaffeoylquinic acidAmyloid beta-Peptides

Autor:innen und Institutionen

  • International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Japan.
  • Biological Science Research Laboratories, Kao Corporation, Ichikai, Japan.
  • Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Life Science Center for Survival Dynamics (TARA), University of Tsukuba, Tsukuba, Japan.
  • R&D Center for Frontiers of Mirai in Policy and Technology (F-MIRAI), University of Tsukuba, Tsukuba, Japan.
  • Department of Biological Sciences, Graduate School of Science, University of Tokyo, Tokyo, Japan.

Zitieren

APA

Suganuma, T., Hatori, S., Chen, C. K., Hori, S., Kanuka, M., Liu, C. Y., Tatsuzawa, C., Yanagisawa, M., & Hayashi, Y. (2024). Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-β Plaque Burden. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-240033

Vancouver

Suganuma T, Hatori S, Chen CK, Hori S, Kanuka M, Liu CY, et al. Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-β Plaque Burden. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-240033

BibTeX
@article{Suganuma2024,
  author = {Suganuma, Takaya and Hatori, Sena and Chen, Chung-Kuan and Hori, Satoshi and Kanuka, Mika and Liu, Chih-Yao and Tatsuzawa, Chika and Yanagisawa, Masashi and Hayashi, Yu},
  title = {Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-β Plaque Burden},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.3233/jad-240033}
}
Kostenlos starten →